Related references
Note: Only part of the references are listed.Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors
Hironobu Sato et al.
CARCINOGENESIS (2007)
Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non-small cell lung cancer
Makoto Suzuki et al.
CLINICAL CANCER RESEARCH (2007)
Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer
M. Nojima et al.
ONCOGENE (2007)
Development of gastric tumors in ApcMin/+ mice by the activation of the β-catenin/Tcf signaling pathway
Hiroyuki Tomita et al.
CANCER RESEARCH (2007)
Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myeloma
Kumar Sukhdeo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Wnt signaling and gastrointestinal tumorigenesis in mouse models
M. M. Taketo
ONCOGENE (2006)
Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer
O. Aguilera et al.
ONCOGENE (2006)
Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis
J. Veeck et al.
ONCOGENE (2006)
Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection
S Urakami et al.
CLINICAL CANCER RESEARCH (2006)
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation
J Ying et al.
ONCOGENE (2006)
PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma
DL Mandelker et al.
CANCER RESEARCH (2005)
Functional epigenomics identifies genes frequently silenced in prostate cancer
D Lodygin et al.
CANCER RESEARCH (2005)
Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer
F Graziano et al.
CLINICAL CANCER RESEARCH (2004)
Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-β-catenin pathway
BH Hoang et al.
CANCER RESEARCH (2004)
Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer
R Stoehr et al.
LABORATORY INVESTIGATION (2004)
Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma
K Kurose et al.
JOURNAL OF UROLOGY (2004)
Liver-targeted disruption of Apc in mice activates β-catenin signaling and leads to hepatocellular carcinomas
S Colnot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Secreted antagonists of the Wnt signalling pathway
Y Kawano et al.
JOURNAL OF CELL SCIENCE (2003)
Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells
K Kobayashi et al.
GENE (2002)
Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas
T Tsuji et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway
JH Mao et al.
MOLECULAR CELL (2001)
Mechanisms of genomic imprinting
K Pfeifer
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer
XM Tang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines
T Tsuji et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
